🇺🇸 FDA
Patent

US 9320789

Combinations of gene deletions for live attenuated shigella vaccine strains

granted A61KA61K2039/522A61K39/0283

Quick answer

US patent 9320789 (Combinations of gene deletions for live attenuated shigella vaccine strains) held by The United States of America, as represented by the Secretary of the Army, on behalf of the Walter Reed Army Institute of Research expires Mon Apr 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary of the Army, on behalf of the Walter Reed Army Institute of Research
Grant date
Tue Apr 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K2039/522, A61K39/0283, A61P, A61P31/04